Identification of circulating murine CD34+OCN+ cells
- PMID: 30340982
- DOI: 10.1016/j.jcyt.2018.07.004
Identification of circulating murine CD34+OCN+ cells
Abstract
Background aims: Previous studies identified a circulating human osteoblastic population that expressed osteocalcin (OCN), increased following fracture and pubertal growth, and formed mineralized colonies in vitro and bone in vivo. A subpopulation expressed CD34, a hematopoietic/endothelial marker. These findings led to our hypothesis that hematopoietic-derived CD34+OCN+ cells exist in the circulation of mice and are modulated after fracture.
Methods: Flow cytometry was used to identify CD34+OCN+ cells in male B6.SJL-PtprcaPepcb/BoyJ and Vav-Cre/mTmG (VavR) mice. Non-stabilized tibial fractures were created by three-point bend. Fractures were longitudinally imaged by micro-computed tomography, and immunofluorescent staining was used to evaluate CD34+OCN+ cells within fracture callus. AMD3100 (10 mg/kg) was injected subcutaneously for 3 days and the CD34+OCN+ population was evaluated by flow cytometry.
Results: Circulating CD34+OCN+ cells were identified in mice and confirmed to be of hematopoietic origin (CD45+; Vav1+) using two mouse models. Both circulating and bone marrow-derived CD34+OCN+ cells peaked three weeks post-non-stabilized tibial fracture, suggesting association with cartilage callus transition to bone and early mineralization. Co-expression of CD34 and OCN in the fracture callus at two weeks post-fracture was observed. By three weeks, there was 2.1-fold increase in number of CD34+OCN+ cells, and these were observed throughout the fracture callus. AMD3100 altered CD34+OCN+ cell levels in peripheral blood and bone marrow.
Discussion: Together, these data demonstrate a murine CD34+OCN+ circulating population that may be directly involved in fracture repair. Future studies will molecularly characterize CD34+OCN+ cells, determine mechanisms regulating their contribution, and examine if their number correlates with improved fracture healing outcomes.
Keywords: circulating osteoprogenitor; fracture; hematopoietic stem cell; mesenchymal stromal cell; mobilization.
Published by Elsevier Inc.
Similar articles
-
Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model.Cytotherapy. 2013 Sep;15(9):1136-47. doi: 10.1016/j.jcyt.2013.05.004. Epub 2013 Jul 3. Cytotherapy. 2013. PMID: 23831362 Free PMC article.
-
Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis.Osteoporos Int. 2010 Feb;21(2):297-306. doi: 10.1007/s00198-009-0968-0. Epub 2009 May 30. Osteoporos Int. 2010. PMID: 19484167
-
Characterization of circulating osteoblast lineage cells in humans.Bone. 2007 May;40(5):1370-7. doi: 10.1016/j.bone.2006.12.064. Epub 2007 Jan 4. Bone. 2007. PMID: 17320497 Free PMC article.
-
Clinical impact of circulating CD34-positive cells on bone regeneration and healing.Tissue Eng Part B Rev. 2014 Jun;20(3):190-9. doi: 10.1089/ten.TEB.2013.0511. Epub 2014 Feb 10. Tissue Eng Part B Rev. 2014. PMID: 24372338 Free PMC article. Review.
-
GPR37 and its neuroprotective mechanisms: bridging osteocalcin signaling and brain function.Front Cell Dev Biol. 2024 Nov 20;12:1510666. doi: 10.3389/fcell.2024.1510666. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39633709 Free PMC article. Review.
Cited by
-
Bioactive Film-Guided Soft-Hard Interface Design Technology for Multi-Tissue Integrative Regeneration.Adv Sci (Weinh). 2022 May;9(15):e2105945. doi: 10.1002/advs.202105945. Epub 2022 Mar 23. Adv Sci (Weinh). 2022. PMID: 35322573 Free PMC article.
-
Circulating osteogenic precursor cells: Building bone from blood.EBioMedicine. 2019 Jan;39:603-611. doi: 10.1016/j.ebiom.2018.11.051. Epub 2018 Dec 3. EBioMedicine. 2019. PMID: 30522933 Free PMC article. Review.
-
New perspective of skeletal stem cells.Biomater Transl. 2022 Dec 28;3(4):280-294. doi: 10.12336/biomatertransl.2022.04.007. eCollection 2022. Biomater Transl. 2022. PMID: 36846511 Free PMC article. Review.
-
Development and validation of a new method to isolate, expand, and differentiate circulating osteogenic precursor (COP) cells.Bone Rep. 2021 Jul 22;15:101109. doi: 10.1016/j.bonr.2021.101109. eCollection 2021 Dec. Bone Rep. 2021. PMID: 34368409 Free PMC article.
-
Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment.J Clin Med. 2022 Aug 14;11(16):4749. doi: 10.3390/jcm11164749. J Clin Med. 2022. PMID: 36012987 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous